Zhixiong Dong

958 total citations
30 papers, 733 citations indexed

About

Zhixiong Dong is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Zhixiong Dong has authored 30 papers receiving a total of 733 indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Molecular Biology, 9 papers in Cancer Research and 8 papers in Oncology. Recurrent topics in Zhixiong Dong's work include RNA modifications and cancer (8 papers), Epigenetics and DNA Methylation (5 papers) and Cancer-related molecular mechanisms research (5 papers). Zhixiong Dong is often cited by papers focused on RNA modifications and cancer (8 papers), Epigenetics and DNA Methylation (5 papers) and Cancer-related molecular mechanisms research (5 papers). Zhixiong Dong collaborates with scholars based in China, Australia and Singapore. Zhixiong Dong's co-authors include Baiqu Huang, Jun Lü, Shan Zhu, Chenfei Kong, Changjun Zhu, Juan Du, Juan Du, Wei Jiang, Yu Zhang and Lina Pan and has published in prestigious journals such as PLoS ONE, Cancer Research and Biochemical Journal.

In The Last Decade

Zhixiong Dong

30 papers receiving 725 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Zhixiong Dong China	15	484	144	132	71	70	30	733
Suvajit Sen United States	17	354 0.7×	106 0.7×	82 0.6×	36 0.5×	60 0.9×	29	744
Ulrike Begley United States	11	998 2.1×	280 1.9×	114 0.9×	31 0.4×	35 0.5×	15	1.3k
Erika P. Rendón‐Huerta Mexico	18	338 0.7×	127 0.9×	117 0.9×	21 0.3×	75 1.1×	35	773
Maro Bujak Croatia	10	497 1.0×	127 0.9×	163 1.2×	53 0.7×	32 0.5×	17	1.0k
Myron K. Evans United States	7	228 0.5×	68 0.5×	106 0.8×	55 0.8×	29 0.4×	12	425
Laura Calleros Spain	15	283 0.6×	86 0.6×	93 0.7×	37 0.5×	41 0.6×	31	581
Junying Zheng United States	17	262 0.5×	74 0.5×	77 0.6×	23 0.3×	22 0.3×	28	625
Yang Hong China	14	220 0.5×	136 0.9×	127 1.0×	53 0.7×	20 0.3×	40	527
Anindya Dey United States	17	482 1.0×	184 1.3×	165 1.3×	24 0.3×	45 0.6×	35	843
Mitchell C. Brenner United States	11	256 0.5×	255 1.8×	77 0.6×	21 0.3×	41 0.6×	14	561

Countries citing papers authored by Zhixiong Dong

Since Specialization

Citations

This map shows the geographic impact of Zhixiong Dong's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zhixiong Dong with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zhixiong Dong more than expected).

Fields of papers citing papers by Zhixiong Dong

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Zhixiong Dong. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zhixiong Dong. The network helps show where Zhixiong Dong may publish in the future.

Co-authorship network of co-authors of Zhixiong Dong

This figure shows the co-authorship network connecting the top 25 collaborators of Zhixiong Dong. A scholar is included among the top collaborators of Zhixiong Dong based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Zhixiong Dong. Zhixiong Dong is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Cao, Jiawei, Tong Zhou, Tom Wu, et al.. (2025). Targeting estrogen-regulated system xc− promotes ferroptosis and endocrine sensitivity of ER+ breast cancer. Cell Death and Disease. 16(1). 30–30. 8 indexed citations

Liu, Shuanghui, et al.. (2024). COX6C expression driven by copy amplification of 8q22.2 regulates cell proliferation via mediation of mitosis by ROS-AMPK signaling in lung adenocarcinoma. Cell Death and Disease. 15(1). 74–74. 5 indexed citations

Zheng, Zhihai, et al.. (2024). Suppressing MTERF3 inhibits proliferation of human hepatocellular carcinoma via ROS-mediated p38 MAPK activation. Communications Biology. 7(1). 18–18. 14 indexed citations

Liang, Xue, et al.. (2023). ARAP1 negatively regulates stress fibers formation and metastasis in lung adenocarcinoma via controlling Rho signaling. Discover Oncology. 14(1). 214–214. 2 indexed citations

Dong, Zhixiong, Jinhai Li, Dongbo Yu, et al.. (2023). RRP15 deficiency induces ribosome stress to inhibit colorectal cancer proliferation and metastasis via LZTS2-mediated β-catenin suppression. Cell Death and Disease. 14(2). 89–89. 12 indexed citations

Zhao, Qi, Xu Yang, Jiaming Zhang, et al.. (2023). Network characterization linc1393 in the maintenance of pluripotency provides the principles for lncRNA targets prediction. iScience. 26(8). 107469–107469. 2 indexed citations

Liu, Shuanghui, Rui Zhang, Yajiao Wang, et al.. (2022). HOXA13 serves as a biomarker to predict neoadjuvant therapy efficacy in advanced colorectal cancer patients. Acta Biochimica et Biophysica Sinica. 55(2). 304–313. 5 indexed citations

Li, Jingyu, Xu Yang, Xiaoyu Liu, et al.. (2022). Metabolic control of histone acetylation for precise and timely regulation of minor ZGA in early mammalian embryos. Cell Discovery. 8(1). 96–96. 66 indexed citations

Liu, Shuanghui, Liang Xu, Yi Zheng, et al.. (2022). Kif4A mediates resistance to neoadjuvant chemoradiotherapy in patients with advanced colorectal cancer via regulating DNA damage response. Acta Biochimica et Biophysica Sinica. 54(7). 940–951. 11 indexed citations

10.

Dong, Zhixiong, et al.. (2019). Ribosomal Protein L15 is involved in Colon Carcinogenesis. International Journal of Medical Sciences. 16(8). 1132–1141. 36 indexed citations

11.

Dong, Zhixiong, Changjun Zhu, Qimin Zhan, & Wei Jiang. (2018). Cdk phosphorylation licenses Kif4A chromosome localization required for early mitotic progression. Journal of Molecular Cell Biology. 10(4). 358–370. 10 indexed citations

12.

Pan, Lina, Yuan Zhang, Changjun Zhu, & Zhixiong Dong. (2017). Kinesin KIF4A is associated with chemotherapeutic drug resistance by regulating intracellular trafficking of lung resistance-related protein. Journal of Zhejiang University SCIENCE B. 18(12). 1046–1054. 16 indexed citations

13.

Dong, Zhixiong, et al.. (2017). HDAC inhibitor PAC-320 induces G2/M cell cycle arrest and apoptosis in human prostate cancer. Oncotarget. 9(1). 512–523. 22 indexed citations

14.

Tao, Yu, Yufeng Yao, Li Shi, et al.. (2012). Distribution of HLA‐G 14‐bp insertion/deletion polymorphism in six Chinese ethnic groups. International Journal of Immunogenetics. 40(2). 93–98. 4 indexed citations

15.

Liu, Zhiwei, Zhixiong Dong, Yueyang Li, et al.. (2012). ATRA Inhibits the Proliferation of DU145 Prostate Cancer Cells through Reducing the Methylation Level of HOXB13 Gene. PLoS ONE. 7(7). e40943–e40943. 31 indexed citations

16.

Wang, Changqing, Liping Wang, Juan Du, et al.. (2011). NEDD9 Is a Positive Regulator of Epithelial-Mesenchymal Transition and Promotes Invasion in Aggressive Breast Cancer. PLoS ONE. 6(7). e22666–e22666. 82 indexed citations

17.

Dong, Zhixiong, Jian Cao, Yang Yang, et al.. (2011). Discovery of polyoxometalate-based HDAC inhibitors with profound anticancer activity in vitro and in vivo. European Journal of Medicinal Chemistry. 46(6). 2477–2484. 62 indexed citations

18.

Du, Juan, Lin Li, Zhouluo Ou, et al.. (2011). FOXC1, a target of polycomb, inhibits metastasis of breast cancer cells. Breast Cancer Research and Treatment. 131(1). 65–73. 80 indexed citations

19.

Zhang, Yu, Yanyan Gao, Guoping Zhang, et al.. (2010). DNMT3a plays a role in switches between doxorubicin‐induced senescence and apoptosis of colorectal cancer cells. International Journal of Cancer. 128(3). 551–561. 51 indexed citations

20.

Tan, Jiang, Jun Lü, Wei Huang, et al.. (2009). Genome-Wide Analysis of Histone H3 Lysine9 Modifications in Human Mesenchymal Stem Cell Osteogenic Differentiation. PLoS ONE. 4(8). e6792–e6792. 43 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact